These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8470761)

  • 1. Complete histologic serial sectioning of a prostate gland with adenocarcinoma.
    Humphrey PA
    Am J Surg Pathol; 1993 May; 17(5):468-72. PubMed ID: 8470761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
    Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens.
    Reyes AO; Humphrey PA
    Am J Clin Pathol; 1998 Apr; 109(4):416-22. PubMed ID: 9535395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels.
    Humphrey PA; Frazier HA; Vollmer RT; Paulson DF
    Cancer; 1993 Mar; 71(5):1821-7. PubMed ID: 7680602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sampling of radical prostatectomy specimens. How much is adequate?
    Cohen MB; Soloway MS; Murphy WM
    Am J Clin Pathol; 1994 Mar; 101(3):250-2. PubMed ID: 8135177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD10 expression pattern in prostatic adenocarcinoma: Elucidation of differences between Gleason's grades.
    Kaur M; Verma S; Gupta R; Pant L; Singh S
    Malays J Pathol; 2018 Apr; 40(1):57-60. PubMed ID: 29704385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
    Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
    Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
    Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC
    J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prostate-specific antigen and the biologic progression of prostate cancer.
    Kabalin JN; McNeal JE; Johnstone IM; Stamey TA
    Urology; 1995 Jul; 46(1):65-70. PubMed ID: 7541589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gleason's histologic grading as clinical prognostic marker in patients with advanced prostatic carcinoma.
    Schwartz CB; Bekirov H; Melman A
    Urology; 1991 Mar; 37(3):198-201. PubMed ID: 2000673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma.
    Villers AA; McNeal JE; Redwine EA; Freiha FS; Stamey TA
    J Urol; 1990 Jun; 143(6):1183-7. PubMed ID: 2342179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-related sequence of tumor distribution pattern in prostate carcinoma: importance of posterior midline crossover in predicting tumor volume, extracapsular extension, and seminal vesicle invasion.
    Torlakovic G; Torlakovic E; Skovlund E; Nesland JM; Reith A; Danielsen HE
    Croat Med J; 2005 Jun; 46(3):429-35. PubMed ID: 15861523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.
    Epstein JI; Partin AW; Potter SR; Walsh PC
    Urology; 2000 Aug; 56(2):283-8. PubMed ID: 10925095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathologic characteristics of pseudohyperplastic prostatic adenocarcinoma].
    Zhang HZ; Jiang ZM; Shi L
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):742-5. PubMed ID: 18307877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with Gleason's histopathologic grading in prostatic cancer.
    Kramer SA; Spahr J; Brendler CB; Glenn JF; Paulson DF
    J Urol; 1980 Aug; 124(2):223-5. PubMed ID: 6995622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic changes induced by neoadjuvant androgen ablation may result in underdetection of positive surgical margins and capsular involvement by prostatic adenocarcinoma.
    Bazinet M; Zheng W; Bégin LR; Aprikian AG; Karakiewicz PI; Elhilali MM
    Urology; 1997 May; 49(5):721-5. PubMed ID: 9145977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods.
    Hall GS; Kramer CE; Epstein JI
    Am J Surg Pathol; 1992 Apr; 16(4):315-24. PubMed ID: 1373577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.